Novo Nordisk Canada has issued a voluntary recall for a lot of its semaglutide injection pens Ozempic due to potential cracked glass cartridges.
The recalled cartridge strength is 1mg 3mL and its lot number is RZFFE55.
The medication is being recalled from wholesalers and pharmacies across the country, according to the company.
Novo Nordisk Canada has notified Health Canada of the issue.
“Patient safety is our top priority at Novo Nordisk. We aim to produce and distribute high-quality products. We apologize for any inconvenience caused by this situation,” the company wrote in an email to CTV News.
The health department is asking users to verify if the product is affected and report any side effects to Health Canada.
It is characterized as a Type II recall, meaning “the use of, or exposure to a recalled product may cause temporary adverse health consequences, or where the probability of serious adverse health consequences is remote,” Health Canada’s website says.
